Cargando…

Tau seeding in cases of multiple sclerosis

Relapsing remitting multiple sclerosis (MS) is an inflammatory demyelinating disorder of the central nervous system that in many cases leads to progressive MS, a neurodegenerative disease. Progressive MS is untreatable and relentless, and its cause is unknown. Prior studies of MS have documented neu...

Descripción completa

Detalles Bibliográficos
Autores principales:	LaCroix, Michael S., Mirbaha, Hilda, Shang, Ping, Zandee, Stephanie, Foong, Chan, Prat, Alexandre, White, Charles L., Stuve, Olaf, Diamond, Marc I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552360/ https://www.ncbi.nlm.nih.gov/pubmed/36221144 http://dx.doi.org/10.1186/s40478-022-01444-2

Ejemplares similares

Seed-competent tau monomer initiates pathology in a tauopathy mouse model
por: Mirbaha, Hilda, et al.
Publicado: (2022)

Site‐Specific Hyperphosphorylation Inhibits, Rather than Promotes, Tau Fibrillization, Seeding Capacity, and Its Microtubule Binding
por: Haj‐Yahya, Mahmood, et al.
Publicado: (2020)

Inert and seed-competent tau monomers suggest structural origins of aggregation
por: Mirbaha, Hilda, et al.
Publicado: (2018)

Spotlight on daclizumab: its potential in the treatment of multiple sclerosis
por: Milo, Ron, et al.
Publicado: (2016)

DnaJC7 specifically regulates tau seeding
por: Perez, Valerie A., et al.
Publicado: (2023)

DnaJC7 specifically regulates tau seeding
por: Perez, Valerie Ann, et al.
Publicado: (2023)

The role of the complement system in Multiple Sclerosis: A review
por: Saez-Calveras, Nil, et al.
Publicado: (2022)

Anti-tau antibodies targeting a conformation-dependent epitope selectively bind seeds
por: Hitt, Brian D., et al.
Publicado: (2023)

VCP increases or decreases tau seeding using specific cofactors
por: Batra, Sushobhna, et al.
Publicado: (2023)

Clinical trials in multiple sclerosis: milestones
por: Zhang, Yinan, et al.
Publicado: (2018)

RNA induces unique tau strains and stabilizes Alzheimer’s disease seeds
por: Zwierzchowski-Zarate, Amy N., et al.
Publicado: (2022)

Targeting “bad” B cells in multiple sclerosis: Could laquinimod be part of the armamentarium?
por: Forsthuber, Thomas G., et al.
Publicado: (2016)

The dual fates of exogenous tau seeds: Lysosomal clearance versus cytoplasmic amplification
por: Kolay, Sourav, et al.
Publicado: (2022)

Editorial: Animal models of multiple sclerosis: can they advance future therapies?
por: DeSilva, Tara Maria, et al.
Publicado: (2023)

Should ocrelizumab be used in non-active primary progressive multiple sclerosis? Time for a re-assessment
por: Manouchehri, Navid, et al.
Publicado: (2021)

Intractable and highly active relapsing multiple sclerosis – role of alemtuzumab
por: Dubey, Divyanshu, et al.
Publicado: (2015)

Ectopic Lymphoid Follicles in Multiple Sclerosis: Centers for Disease Control?
por: Negron, Austin, et al.
Publicado: (2020)

Evolution of clinical trials in multiple sclerosis
por: Zhang, Yinan, et al.
Publicado: (2019)

T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy
por: Reder, Anthony T, et al.
Publicado: (2022)

Multiplexed imaging of immune cells in staged multiple sclerosis lesions by mass cytometry
por: Ramaglia, Valeria, et al.
Publicado: (2019)

CLMP Promotes Leukocyte Migration Across Brain Barriers in Multiple Sclerosis
por: Fournier, Antoine Philippe, et al.
Publicado: (2022)

The validity of animal models to explore the pathogenic role of the complement system in multiple sclerosis: A review
por: Saez-Calveras, Nil, et al.
Publicado: (2022)

Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer’s disease and PART
por: Kaufman, Sarah K., et al.
Publicado: (2018)

Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis
por: Warnke, Clemens, et al.
Publicado: (2011)

Review of teriflunomide and its potential in the treatment of multiple sclerosis
por: Warnke, Clemens, et al.
Publicado: (2009)

To the editors: Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England
por: Tugemann, Bastian, et al.
Publicado: (2022)

Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine
por: Warnke, Clemens, et al.
Publicado: (2010)

Stress Signal ULBP4, an NKG2D Ligand, Is Upregulated in Multiple Sclerosis and Shapes CD8(+) T-Cell Behaviors
por: Carmena Moratalla, Ana, et al.
Publicado: (2021)

Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis
por: Sánchez-Fernández, Alba, et al.
Publicado: (2022)

Characterization of tau prion seeding activity and strains from formaldehyde-fixed tissue
por: Kaufman, Sarah K., et al.
Publicado: (2017)

Alzheimer's disease risk modifier genes do not affect tau aggregate uptake, seeding or maintenance in cell models
por: Kolay, Sourav, et al.
Publicado: (2020)

Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF
por: Hitt, Brian D., et al.
Publicado: (2021)

DnaJC7 binds natively folded structural elements in tau to inhibit amyloid formation
por: Hou, Zhiqiang, et al.
Publicado: (2021)

Disease-modifying therapy prescription patterns in people with multiple sclerosis by age
por: Zhang, Yinan, et al.
Publicado: (2021)

THE WOMEN'S HEALTH INITIATIVE (WHI): STILL LEARNING FROM 161,808 POSTMENOPAUSAL WOMEN
por: LaCroix, Andrea Z, et al.
Publicado: (2019)

Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo
por: Vasconcelos, Bruno, et al.
Publicado: (2016)

Cognitive Decline in Older People with Multiple Sclerosis—A Narrative Review of the Literature
por: Chiang, Hsueh-Sheng, et al.
Publicado: (2022)

A systematic review of the incidence and prevalence of cancer in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_n3elms960vj1vam3th3ac1kc1s